These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3914359)

  • 1. [Prostaglandins and ischemic cardiopathy].
    Strano A; Davì G
    Cardiologia; 1985 Apr; 30(4):261-4. PubMed ID: 3914359
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prostaglandins and ischemic cardiopathy].
    Patrono C; De Caterina R; Maseri A
    G Ital Cardiol; 1980; 10(10):1371-82. PubMed ID: 7016653
    [No Abstract]   [Full Text] [Related]  

  • 3. [The role of prostacycline, thromboxane A2 and prostaglandins in platelet aggregation (author's transl)].
    Herman AG
    Rev Med Brux; 1981 Mar; 2(3):251-7. PubMed ID: 7015444
    [No Abstract]   [Full Text] [Related]  

  • 4. [Status of the prostacyclin-thromboxane A2 system in patients with ischemic heart disease during induced myocardial ischemia].
    Nikolaeva LF; Aleshin OI; Pavlov NA; Pomerantsev EV; Masenko VP
    Sov Med; 1988; (4):3-6. PubMed ID: 3043710
    [No Abstract]   [Full Text] [Related]  

  • 5. [Blood thromboxane A2 and prostaglandin I2 levels and platelet phospholipid fatty acid composition ratios in ischemic heart disease and cerebral infarction--with special reference to the effect of antiplatelet agents].
    Inoue T
    Nihon Ronen Igakkai Zasshi; 1983 Jul; 20(4):294-304. PubMed ID: 6363769
    [No Abstract]   [Full Text] [Related]  

  • 6. [Stenocardia. Thromboxane A2 and prostacyclin].
    Panchenko EP
    Kardiologiia; 1986 Jul; 26(7):109-16. PubMed ID: 3093749
    [No Abstract]   [Full Text] [Related]  

  • 7. [Kinetics of thromboxane A2 and prostacyclin during reperfusion after induced ischemia in canine hearts].
    Nomura F; Hirose H; Matsuda H; Nakano S; Shirakura R; Ohtani M; Kaneko M; Sasako Y; Kawashima Y; Kuzuya T
    Kyobu Geka; 1985 Jan; 38(1):46-9. PubMed ID: 3884863
    [No Abstract]   [Full Text] [Related]  

  • 8. [The level of vasoactive prostanoids in patients with ischemic heart disease in the early period following aortocoronary bypass].
    Bakhoviddinova GSh
    Vrach Delo; 1991 Sep; (9):36-8. PubMed ID: 1759428
    [No Abstract]   [Full Text] [Related]  

  • 9. Thromboxane and prostacyclin: implications for function and disease of the vasculature.
    McGiff JC
    Adv Intern Med; 1980; 25():199-216. PubMed ID: 6987841
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ischemic heart disease and prostanoids: pathogenesis and its implications for treatment].
    Aoyama T; Yui Y; Hattori R; Kawai C
    Nihon Rinsho; 1990 Jun; 48(6):1229-33. PubMed ID: 2117082
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacological correction of disorders of the prostacyclin- thromboxane balance in ischemic heart disease: problems and prospects].
    Markov KhM
    Kardiologiia; 1990 Apr; 30(4):111-8. PubMed ID: 2118578
    [No Abstract]   [Full Text] [Related]  

  • 12. A study of platelet aggregation, thromboxane A2 and prostacyclin in central aortic and coronary sinus blood in ischemic heart disease.
    Narain VS; Bhargava B; Chandra N; Puri VK; Hasan M
    Indian Heart J; 1994; 46(4):149-52. PubMed ID: 7875701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thromboxane and prostacyclin in disease: a review.
    Halushka PV; Dollery CT; MacDermot J
    Q J Med; 1983; 52(208):461-70. PubMed ID: 6361838
    [No Abstract]   [Full Text] [Related]  

  • 14. [Platelet aggregation and endogenous prostaglandins and thromboxane (author's transl)].
    Katori M
    No Shinkei Geka; 1980 Aug; 8(8):717-22. PubMed ID: 6999371
    [No Abstract]   [Full Text] [Related]  

  • 15. Recent concepts on platelet function and dietary lipids in coronary thrombosis, vasospasm and angina.
    Lands WE; Pitt BW; Culp BR
    Herz; 1980 Feb; 5(1):34-41. PubMed ID: 7007191
    [No Abstract]   [Full Text] [Related]  

  • 16. [The role of prostaglandins in the development of cardio- and hemodynamic disorders in postischemic shock].
    Sagach VF; Zhukova AV
    Fiziol Zh (1978); 1991; 37(2):25-31. PubMed ID: 1905243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phenotypic familial correlations of prostacyclin and thromboxane A2 levels in children and adolescents with or without hereditary predisposition to ischemic heart disease].
    Akimov EV
    Kardiologiia; 1992 May; 32(5):41-3. PubMed ID: 1405259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-suppressive therapy in cardiovascular disease.
    Mehta J; Roy L
    Cardiovasc Clin; 1984; 14(3):211-34. PubMed ID: 6722852
    [No Abstract]   [Full Text] [Related]  

  • 19. Prostacyclin in physiology and pathophysiology.
    Vane JR; Bunting S; Moncada S
    Int Rev Exp Pathol; 1982; 23():161-207. PubMed ID: 6806207
    [No Abstract]   [Full Text] [Related]  

  • 20. [Biochemistry of coronary artery disease--prostaglandins].
    Tada M; Kuzuya T; Ohmori M
    Rinsho Byori; 1983 Aug; 31(8):854-9. PubMed ID: 6361336
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.